The use of inhaled corticosteroids (ICS) in combination with inhaled bronchodilators for
patients with chronic obstructive pulmonary disease (COPD) is a common practice in …

Inhaled and systemic corticosteroids are commonly prescribed for the treatment of COPD.
Despite their frequent use, there is insufficient evidence regarding efficacy of steroid therapy …

Inhaled corticosteroids have a proven benefit in the management of asthma, but until
recently, their efficacy in non-asthmatic, smoking-related chronic obstructive pulmonary …

Inhaled corticosteroids (ICSs) are widely used in chronic obstructive pulmonary disease
(COPD). Since inflammatory processes play a key role in the pathogenesis of the disease …

Background Inhaled corticosteroids (ICS) reduce exacerbation rates and improve health
status but can increase the risk of pneumonia in COPD. The GLUCOLD study, investigating …

Although inhaled corticosteroids have a well defined role in asthma therapy, their use
remains controversial in nonasthmatic, smoking-related chronic obstructive pulmonary …

Inhaled corticosteroids in chronic obstructive pulmonary dis... : Current Opinion in Pulmonary
Medicine Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a long-term …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

Background The use of inhaled corticosteroids (ICS) in combination with bronchodilators in
patients with COPD has been shown to decrease the rate of disease exacerbations and to …

The effects of inhaled corticosteroids (ICSs) have been investigated in asthma and chronic
obstructive pulmonary disease (COPD) using endobronchial biopsies. In asthma, most …